Trials / Completed
CompletedNCT02848768
Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- Rennes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to validate of a predictive nomogram of response or resistance to targeted therapies in metastatic clear cell renal cell carcinoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sunitinib |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-03-01
- First posted
- 2016-07-28
- Last updated
- 2016-07-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02848768. Inclusion in this directory is not an endorsement.